No exercises of the 20th to 22nd series stock acquisition rights occurred in December 2025; exercise was suspended after November 28 and the rights were acquired and cancelled on December 8.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3350","jir_company_name":"Metaplanet Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-01-05","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/01\/3350-20260105-01.pdf","jir_short_summary":"No exercises of the 20th to 22nd series stock acquisition rights occurred in December 2025; exercise was suspended after November 28 and the rights were acquired and cancelled on December 8.","jir_summary":"### Overview of Capital Policy\nMetaplanet Co., Ltd. issued the 20th to 22nd series stock acquisition rights to EVO FUND as the allottee on June 23, 2025. These rights include provisions for exercise price adjustment and exercise suspension. No exercises occurred during the month of December 2025. Exercise suspension has been in place since November 28, 2025, and these stock acquisition rights were acquired and cancelled on December 8, 2025. The exercise price was first adjusted on June 25, 2025, and is subsequently adjusted every three trading days, with a lower limit set at 637 yen.\n\n### Impact on Shareholders and Future Outlook\nAs of the end of December 2025, the outstanding number of the 20th series stock acquisition rights was 284,400 units (28,440,000 shares), while for the 21st and 22nd series it was 1,850,000 units (185,000,000 shares) each. However, as all were acquired and cancelled on December 8, the dilution risk has been eliminated. The exercise ratio relative to the number of listed shares is 0%, and there is currently no share dilution. Future issuance and exercises of stock acquisition rights should be monitored based on separately published information.","jir_financial_highlights":"Outstanding 20th Series Stock Acquisition Rights (End of November): 284,400 units (28,440,000 shares) (Unknown)\nOutstanding 21st Series Stock Acquisition Rights (End of November): 1,850,000 units (185,000,000 shares) (Unknown)\nOutstanding 22nd Series Stock Acquisition Rights (End of November): 1,850,000 units (185,000,000 shares) (Unknown)\nStock Acquisition Rights Exercised in December 2025: 0 units (Unknown)\nNumber of Listed Shares (End of December 2025): 600,714,340 shares (Unknown)","jir_category":"","jir_hashtags":"#MetaplanetCoLtd, #CapitalPolicy, #StockAcquisitionRights","jir_key_figures":"Outstanding 20th Series Stock Acquisition Rights (End of November): 284,400 units (28,440,000 shares)\nOutstanding 21st Series Stock Acquisition Rights (End of November): 1,850,000 units (185,000,000 shares)\nAcquisition and cancellation of the 20th to 22nd Series Stock Acquisition Rights on December 8, 2025","jir_meta_title":"Metaplanet Co., Ltd. December 2025 Exercise Status and Cancellation of 20th to 22nd Series Stock Acquisition Rights","jir_meta_description":"Metaplanet Co., Ltd. had no exercises of the 20th to 22nd series stock acquisition rights in December 2025, suspended exercise from November 28, and acquired and cancelled them on December 8. Dilution risk has been resolved.","jir_og_title":"Metaplanet Co., Ltd. Notice Regarding Suspension and Cancellation of Stock Acquisition Rights","jir_og_description":"No exercises of stock acquisition rights in December 2025; exercise suspended from November 28 and cancelled on December 8. Share dilution risk resolved.","jir_og_image_url":"\/assets\/og\/company-capital_policy.jpg","jir_chart_data_collection":"[]","ir_related_company":7876,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"capital_policy","footnotes":""},"sector":[],"importance":[],"class_list":["post-10682","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n